{"date":"2026-02-12","count":30,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6535-2026-02-12-2145-f7zdi0","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"21:45:22","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-02-12 21:45，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1941-szdj7n","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:41:56","subject":"本公司董事會決議114年不分派股利","clause":"第14款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:41，「本公司董事會決議114年不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1940-11b1948","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:40:48","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:40，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1939-nq3yxb","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:39:52","subject":"公告本公司董事會決議不分派114年度員工酬勞及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:39，「公告本公司董事會決議不分派114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1939-5j9yh6","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:39:01","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:39，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1938-u5u6if","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:38:17","subject":"代重要子公司科進製藥科技股份有限公司公告董事會代行115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:38，「代重要子公司科進製藥科技股份有限公司公告董事會代行115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1937-2ehviv","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:37:47","subject":"代重要子公司科進製藥科技股份有限公司公告董事會決議通過114年度員工酬勞及董監事酬勞分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:37，「代重要子公司科進製藥科技股份有限公司公告董事會決議通過114年度員工酬勞及董監事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1937-lcijfg","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:37:09","subject":"代重要子公司科進製藥科技股份有限公司公告董事會決議分派114年度股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:37，「代重要子公司科進製藥科技股份有限公司公告董事會決議分派114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-02-12-1936-pjj8a3","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"19:36:34","subject":"代子公司科進製藥科技股份有限公司公告董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-02-12 19:36，「代子公司科進製藥科技股份有限公司公告董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-02-12-1756-17snutz","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"17:56:25","subject":"公告本公司董事會決議召開民國115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-02-12 17:56，「公告本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-02-12-1739-uyr4wo","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"17:39:12","subject":"本公司董事會決議通過114年度股東常會通過之有價證券私募案不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-02-12 17:39，「本公司董事會決議通過114年度股東常會通過之有價證券私募案不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-02-12-1737-1p16wuj","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"17:37:43","subject":"本公司董事會通過提案至股東常會討論辦理私募普通股（僅為股東常會例行性提案，目前並無確切規劃）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-02-12 17:37，「本公司董事會通過提案至股東常會討論辦理私募普通股（僅為股東常會例行性提案，目前並無確切規劃）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-02-12-1734-f1yp7a","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"17:34:57","subject":"本公司董事會通過提案至股東常會討論以詢價圈購或競價拍賣方式辦理現金增資發行普通股（僅為股東常會例行性提案，目前並無確切規劃）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-02-12 17:34，「本公司董事會通過提案至股東常會討論以詢價圈購或競價拍賣方式辦理現金增資發行普通股（僅為股東常會例行性提案，目前並無確切規」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-02-12-1734-wj1b9d","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"17:34:12","subject":"本公司董事會通過提案至股東常會討論辦理現金增資發行普通股參與發行海外存託憑證（僅為股東常會例行性提案，目前並無確切規劃）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-02-12 17:34，「本公司董事會通過提案至股東常會討論辦理現金增資發行普通股參與發行海外存託憑證（僅為股東常會例行性提案，目前並無確切規劃）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-02-12-1724-127w91f","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-12","time":"17:24:51","subject":"衛福部核准彰化基督教醫療財團法人彰化基督教醫院與本公司合作之「自體免疫細胞(DC)治療第一期至第三期實體癌，經標準療無效」之細胞治療技術施行計畫 。","clause":"第44款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-02-12 17:24，「衛福部核准彰化基督教醫療財團法人彰化基督教醫院與本公司合作之「自體免疫細胞(DC)治療第一期至第三期實體癌，經標準療無效」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-02-12-1719-1qw9q8i","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"17:19:28","subject":"114年第4季財務報告董事會預計召開日期為115年2月25日。","clause":"第31款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-02-12 17:19，「114年第4季財務報告董事會預計召開日期為115年2月25日。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-02-12-1621-w7lk89","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"16:21:26","subject":"公告114年度財務報告董事會預計召開日期為115年2月23日","clause":"第31款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-02-12 16:21，「公告114年度財務報告董事會預計召開日期為115年2月23日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-02-12-1526-13f2e6o","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-02-12","time":"15:26:00","subject":"代重要子公司Alvogen Korea Holdings Ltd.公告召開2026年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-02-12 15:26，「代重要子公司Alvogen Korea Holdings Ltd.公告召開2026年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-02-12-1525-vrus44","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-02-12","time":"15:25:46","subject":"代重要子公司Alvogen Korea Co., Ltd.公告召開2026年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-02-12 15:25，「代重要子公司Alvogen Korea Co., Ltd.公告召開2026年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-02-12-1513-1fqkmsr","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-02-12","time":"15:13:02","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-02-12 15:13，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-02-12-1512-15queq4","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-02-12","time":"15:12:19","subject":"公告本公司二廠火災事件說明","clause":"第21款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-02-12 15:12，「公告本公司二廠火災事件說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-02-12-1507-1tjvw7y","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-02-12","time":"15:07:31","subject":"公告本公司民國114年第四季財務報告董事會預計召開日期為115年02月24日","clause":"第31款","fact_date":"2026-02-12","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-02-12 15:07，「公告本公司民國114年第四季財務報告董事會預計召開日期為115年02月24日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-02-12-1448-18mwumo","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-02-12","time":"14:48:23","subject":"代重要子公司Tanvex BioPharma USA, Inc.公告新任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-02-12 14:48，「代重要子公司Tanvex BioPharma USA, Inc.公告新任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-02-12-1447-1glg129","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-02-12","time":"14:47:39","subject":"代重要子公司Tanvex BioPharma USA, Inc.公告單一法人股東指派董事暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-02-12 14:47，「代重要子公司Tanvex BioPharma USA, Inc.公告單一法人股東指派董事暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-02-12-1435-8jz32o","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-02-12","time":"14:35:11","subject":"公告本公司114年度現金增資股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-02-12 14:35，「公告本公司114年度現金增資股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-02-12-1401-15z6ddo","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-02-12","time":"14:01:35","subject":"公告本公司114年第四季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-02-12 14:01，「公告本公司114年第四季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-02-12-1355-6p3sfx","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-02-12","time":"13:55:00","subject":"公告本公司經主管機關核准撤銷114年第1次現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-02-12 13:55，「公告本公司經主管機關核准撤銷114年第1次現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-02-12-1054-3g5qc4","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-02-12","time":"10:54:33","subject":"澄清經濟日報115年2月12日報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-02-12 10:54，「澄清經濟日報115年2月12日報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-02-12-1040-1bkm0mx","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-12","time":"10:40:23","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-02-12 10:40，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-02-12-1039-p9bs5i","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-12","time":"10:39:45","subject":"公告本公司重要營運主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-02-12 10:39，「公告本公司重要營運主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}